# Observational Macular Degeneration studies: 55 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 55 trials that are observational for Macular Degeneration that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting observational Macular Degeneration studies: 55 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 2 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/observational/macular-degeneration

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 55
- Recruiting or not yet: 55
- Read on: November 19, 2026

## Trials

The 25 newest of 55, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| October 27, 2026 | NCT07897513 | A Case-Control Study Revealing Intraocular Microenvironment Characteristics in Patients With Ocular Diseases Based on Multi-Omics Analysis | First Affiliated Hospital of Zhejiang University | Observational | Not yet recruiting | Age- Related Macular Degeneration, Diabetic Retinopathy, Retinal Vein Occlusion, Central Serous Chorioretinopathy... | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07897513) |
| October 21, 2026 | NCT07886177 | Prevalence of Age-Related Macular Degeneration in Assiut University Hospitals | Assiut University | Observational | Not yet recruiting | Age-Related Macular Degeneration (AMD) | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07886177) |
| September 29, 2026 | NCT07847151 | MIND-AMD Study: a Multidisciplinary Investigation of Neuroretinal Damage in Age-related Macular Degeneration. | IRCCS San Raffaele | Observational | Not yet recruiting | Age-Related (Dry) Macular Degeneration, Age-Related Macular Degeneration (AMD), AMD Population - Intermediate or... | 160 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07847151) |
| September 15, 2026 | NCT07821450 | Blepharoptosis After Repeated Intravitreal Anti-VEGF Injections: A Prospective Study | Sponsor not shown (see the record) | Observational | Recruiting | Blepharoptosis, Age-Related Macular Degeneration, Diabetic Macular Edema | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07821450) |
| September 1, 2026 | NCT07798323 | Noninvasive Imaging Biomarkers of Treatable Macrovascular Disease in Age-related Macular Degeneration. | Sponsor not shown (see the record) | Observational | Recruiting | Macular Degeneration | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07798323) |
| June 17, 2026 | NCT07653269 | Predicting Risk of Progression of Early to Late AMD in the Aging Eye Through Imaging and Multimodal Evaluation | Singapore National Eye Centre | Observational | Recruiting | Age Related Macular Degeneration | 1,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07653269) |
| April 29, 2026 | NCT07556406 | Central micrOperimetry and Radial OCT Evaluation in Geographic Atrophy (CORE-GA): a Prospective Pilot Study | University of California, San Francisco | Observational | Recruiting | Age-Related Macular Degeneration, Geographic Atrophy | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07556406) |
| April 24, 2026 | NCT07550777 | Serum Cholinesterases, Paraoxonase, and Cardiovascular Risk After Intravitreal Bevacizumab | Ataturk University | Observational | Recruiting | Diabete Mellitus, Retina Vein Occlusion, Age Macular Degeneration | 180 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07550777) |
| April 7, 2026 | NCT07515521 | Enhanced Vision and Imaging Tests for Enabling Treatment Trials in Early and Intermediate AMD | Sponsor not shown (see the record) | Observational | Recruiting | Age - Related Macular Degeneration (AMD) | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07515521) |
| March 27, 2026 | NCT07497815 | Artificial Intelligence-assisted Diagnosis in Ophthalmology | Sponsor not shown (see the record) | Observational | Not yet recruiting | Macular Degeneration, Diabetic Retinopathy (DR), Glaucoma, Keratoconus, Cataract | 15,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07497815) |
| March 3, 2026 | NCT07446582 | Real-World Evaluation of AI Enabled Multi-Spectral Imaging (MSI) for AMD Biomarker Detection | AI-Spectral | Observational | Recruiting | Age-Related (Dry) Macular Degeneration | 1,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07446582) |
| February 27, 2026 | NCT07434713 | EarLy Treatment Response in nEoVascular Macular Degeneration With Eylea 8mg: ELEV8 A Prospective Observational Open Label Study... | Insel Gruppe AG, University Hospital Bern | Observational | Recruiting | Age-Related Macular Degeneration (AMD) | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07434713) |
| February 23, 2026 | NCT07427160 | Prognostic Role of Macular Neovascular Membrane Subtype in Pneumatic Displacement of Macular Hemorrhages | Sponsor not shown (see the record) | Observational | Recruiting | AMD - Age-Related Macular Degeneration | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07427160) |
| February 23, 2026 | NCT07425574 | A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults | Astellas Pharma Global Development, Inc. | Observational | Recruiting | Stargardt Disease, Stargardt Macular Dystrophy, Stargardt-like Macular Dystrophy | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07425574) |
| December 23, 2025 | NCT07298174 | Wide Field OCTA in Ocular Diseases | IRCCS San Raffaele | Observational | Not yet recruiting | Age - Related Macular Degeneration (AMD), Diabetic Macular Edema, Diabetic Retinopathy, Myopia, Inherited Retinal... | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07298174) |
| November 25, 2025 | NCT07249307 | High-throughput Large-model-based AI-assisted Diagnosis Using OCT | Peking Union Medical College Hospital | Observational | Not yet recruiting | Diabetic Retinopathy (DR), Retinal Vein Occlusion (RVO), Age-Related Macular Degeneration (AMD), Pathologic Myopia... | 2,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07249307) |
| August 27, 2025 | NCT07144137 | A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA) | Complement Therapeutics | Observational | Recruiting | Geographic Atrophy Secondary to Age-related Macular Degeneration | 75 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07144137) |
| August 27, 2025 | NCT07143526 | Comparison of the Sensibility of Swept Source Optical Coherence Tomography Devices in the Detection of Neovascularisation in Large Pigment... | University of Trieste | Observational | Not yet recruiting | AMD - Age-Related Macular Degeneration | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07143526) |
| August 22, 2025 | NCT07135570 | "My Eyes, My Light": Amar Chokh, Amar Alo | Data Yakka, Inc. | Observational | Recruiting | Glaucoma, Diabetic Retinopathy (DR), Hypertensive Retinopathy, Cataract, AMD - Age-Related Macular Degeneration... | 20,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07135570) |
| July 25, 2025 | NCT07085533 | Natural History Study of Inherited Retinal Diseases | Augelux Therapeutics | Observational | Recruiting | Retinal Dystrophies, Color Vision Defects, Vision Disorders, Macular Degeneration, Achromatopsia, Optical Coherence... | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07085533) |
| July 25, 2025 | NCT07084883 | Pivotal Trial of an Automated AI-based System for Early Diagnosis and Prediction of Late Age-related Macular Degeneration | iHealthScreen Inc | Observational | Recruiting | Age-related Macular Degeneration (AMD) | 1,076 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07084883) |
| July 11, 2025 | NCT07060196 | The Impact of Artificial Lighting on the Visual Capacity of Patients With Age-Related Macular Degeneration | Democritus University of Thrace | Observational | Not yet recruiting | AMD - Age-Related Macular Degeneration | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07060196) |
| June 4, 2025 | NCT07004361 | Ethical Issues of Using Gene Therapy in the Treatment of AMD | Nantes University Hospital | Observational | Recruiting | Exudative Age-related Macular Degeneration | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07004361) |
| June 4, 2025 | NCT07003165 | Research on a New Intelligent Mobile Screening and Diagnosis Pattern for Ocular Diseases | Zhongshan Ophthalmic Center, Sun Yat-sen University | Observational | Not yet recruiting | Ophthalmic Diseases (Specific Types Not Restricted), Cataract, Refraction Error, Diabetic Retinopathy (DR), Age Related... | 15,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07003165) |
| April 11, 2025 | NCT06924021 | Age-Related Macular Degeneration Benchmark Imaging Dataset (ABID) | University of Wisconsin, Madison | Observational | Recruiting | Age-Related Macular Degeneration | 1,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06924021) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Medical University of Vienna | 3 |
| Zhongshan Ophthalmic Center, Sun Yat-sen University | 3 |
| Assiut University | 2 |
| National Eye Institute (NEI) | 2 |
| Nantes University Hospital | 2 |
| Center for Eye Research Australia | 2 |
| IRCCS San Raffaele | 2 |
| Democritus University of Thrace | 1 |
| Skyline Therapeutics | 1 |
| Institut National de la Santé Et de la Recherche Médicale, France | 1 |
| [Astellas Pharma Global Development, Inc.](https://specstream.ai/data/clinical-trials/company/astellas-pharma-global-development-inc) | 1 |
| University of California, San Francisco | 1 |
| AI-Spectral | 1 |
| Fondazione G.B. Bietti, IRCCS | 1 |
| Ataturk University | 1 |
| Peking Union Medical College Hospital | 1 |
| University of Wisconsin, Madison | 1 |
| Hadassah Medical Organization | 1 |
| Wills Eye | 1 |
| Complement Therapeutics | 1 |
| Oregon Health and Science University | 1 |
| University of Trieste | 1 |
| Nanoscope Therapeutics Inc. | 1 |
| Retinal Care Inc. | 1 |
| Johannes Kepler University of Linz | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 17 |
| France | 8 |
| Austria | 4 |
| United Kingdom | 4 |
| China | 3 |
| Switzerland | 3 |
| Italy | 3 |
| Australia | 3 |
| Turkey (Türkiye) | 2 |
| Slovenia | 2 |
| Spain | 2 |
| Germany | 2 |
| South Korea | 2 |
| Greece | 1 |
| Costa Rica | 1 |
| Argentina | 1 |
| India | 1 |
| Pakistan | 1 |
| Israel | 1 |
| Bangladesh | 1 |
| Egypt | 1 |
| Singapore | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Stone suppliers in the United States](https://specstream.ai/data/businesses/stone-suppliers/united-states)
- [B2B radio and television commercials companies in the United States](https://specstream.ai/data/businesses/b2b-radio-and-television-commercials-companies/united-states)
- [Elementary schools in the United States](https://specstream.ai/data/businesses/elementary-schools/united-states)
- [Language schools in the United States](https://specstream.ai/data/businesses/language-schools/united-states)
- [Real estate firms in the United States](https://specstream.ai/data/businesses/real-estate-firms/united-states)
- [Acupuncture clinics in the United States](https://specstream.ai/data/businesses/acupuncture-clinics/united-states)
